The Chemours Company
CC
$14.62
-$0.3625-2.42%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 5.88B | 5.82B | 5.81B | 5.83B | 5.82B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.88B | 5.82B | 5.81B | 5.83B | 5.82B |
| Cost of Revenue | 4.81B | 4.71B | 4.66B | 4.70B | 4.70B |
| Gross Profit | 1.07B | 1.10B | 1.15B | 1.13B | 1.12B |
| SG&A Expenses | 607.00M | 581.00M | 596.00M | 530.00M | 556.00M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.52B | 5.40B | 5.37B | 5.34B | 5.36B |
| Operating Income | 356.00M | 414.00M | 446.00M | 494.00M | 456.00M |
| Income Before Tax | -282.00M | 48.00M | 118.00M | 40.00M | 83.00M |
| Income Tax Expenses | 137.00M | 27.00M | 39.00M | -31.00M | -27.00M |
| Earnings from Continuing Operations | -419.00 | 21.00 | 79.00 | 71.00 | 110.00 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -1.00M | -- | -- | -2.00M | -2.00M |
| Net Income | -420.00M | 21.00M | 79.00M | 69.00M | 108.00M |
| EBIT | 356.00M | 414.00M | 446.00M | 494.00M | 456.00M |
| EBITDA | 669.00M | 721.00M | 747.00M | 791.00M | 751.00M |
| EPS Basic | -2.80 | 0.14 | 0.53 | 0.46 | 0.72 |
| Normalized Basic EPS | 0.55 | 0.80 | 0.96 | 1.12 | 0.99 |
| EPS Diluted | -2.81 | 0.12 | 0.51 | 0.44 | 0.70 |
| Normalized Diluted EPS | 0.55 | 0.80 | 0.96 | 1.11 | 0.99 |
| Average Basic Shares Outstanding | 599.68M | 598.86M | 597.97M | 597.01M | 595.93M |
| Average Diluted Shares Outstanding | 599.68M | 599.57M | 599.70M | 598.73M | 599.22M |
| Dividend Per Share | 0.84 | 1.00 | 1.00 | 1.00 | 1.00 |
| Payout Ratio | -29.52% | 704.76% | 187.34% | 215.94% | 137.04% |